Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Genocea Biosciences (GNCA)
OTHER OTC:GNCA
Genocea Biosciences (GNCA) Stock Price & Analysis
0 Followers
GNCA Stock Chart & Stats
Day’s Range$0.0001 - $0.0001
52-Week Range― - ―
Previous Close$0.0011
Volume30.27K
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding58,783,503
10 Day Avg. Volume1,057,991
30 Day Avg. Volume539,832
Standard Deviation0.27
R-Squared0.12
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.74
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genocea Biosciences News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GNCA FAQ
What was Genocea Biosciences’s price range in the past 12 months?
Currently, no data Available
What is Genocea Biosciences’s market cap?
Currently, no data Available
When is Genocea Biosciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genocea Biosciences’s earnings last quarter?
Currently, no data Available
Is Genocea Biosciences overvalued?
According to Wall Street analysts Genocea Biosciences’s price is currently Overvalued.
Does Genocea Biosciences pay dividends?
Genocea Biosciences does not currently pay dividends.
What is Genocea Biosciences’s EPS estimate?
Genocea Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genocea Biosciences have?
Currently, no data Available
What happened to Genocea Biosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Genocea Biosciences?
Currently, no hedge funds are holding shares in GNCA
---
Genocea Biosciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
Genocea Biosciences
Genocea Biosciences, Inc. engages in the development and commercialization of cancer vaccines. It uses its proprietary technology platform ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-003, an investigational immunotherapy for the treatment of genital herpes; and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
FluoroPharma Medical
―
Predictive Technology Group
―
Kiwa Bio-Tech Products Group
―
Cell Source
―
Arno Therapeutics
―
---